A US patent has been issued to Dr. En Huang for the invention of linear lipopeptide antimicrobial agents, known as paenipeptins. These compounds exhibit potent antimicrobial activity against a variety of multidrug-resistant bacterial pathogens (superbugs). Paenipeptins hold substantial promise as candidates for further development in the treatment of bacterial infections.
Dr. Huang’s research in this field is ongoing.
